|Year : 2008 | Volume
| Issue : 4 | Page : 403-405
Rubella in Delhi: In-utero infection and congenital rubella syndrome
I Gandhoke, R Aggarwal, S Lal, S Khare
Department of Microbiology, National Institute of Communicable Diseases, Directorate General of Health Services, New Delhi-110 054, India
|Date of Submission||26-Feb-2008|
|Date of Acceptance||17-Mar-2008|
Department of Microbiology, National Institute of Communicable Diseases, Directorate General of Health Services, New Delhi-110 054
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Gandhoke I, Aggarwal R, Lal S, Khare S. Rubella in Delhi: In-utero infection and congenital rubella syndrome. Indian J Med Microbiol 2008;26:403-5
|How to cite this URL:|
Gandhoke I, Aggarwal R, Lal S, Khare S. Rubella in Delhi: In-utero infection and congenital rubella syndrome. Indian J Med Microbiol [serial online] 2008 [cited 2017 Jul 25];26:403-5. Available from: http://www.ijmm.org/text.asp?2008/26/4/403/43559
Importance of rubella infection, which otherwise is a mild infection, arises from its teratogenic effects in foetus in case of primary maternal rubella infection. This may lead to foetal death and cause spontaneous abortion or the foetus may survive and bear multiple congenital defects after birth called congenital rubella syndrome (CRS). CRS is an important cause of deafness, heart disease, cataract, mental retardation and variety of other permanent sequelae in children. ,
Rubella testing of blood samples referred from Delhi-based government hospitals is being carried out at NICD for the past 20 years.The samples are received for serosurveillance of women of child-bearing age for rubella antibodies, pregnant women for diagnosis of suspected in-utero rubella infection, retrospective diagnosis of role of rubella virus in women with recent abortion and retrospective serosurveillance of congenital rubella syndrome in babies with congenital anomalies. In our previous study,  the compiled data of 15 years (1988-2002) showed the gradual declining trend of in-utero rubella infection in women with increasing trend of rubella immunity status among the women of child-bearing age at Delhi. Significant decline in CRS cases could also be seen from the study However, periodic increase in rubella infection cases in pregnant women followed by increase in CRS cases in children was apparent from the study. In the present study, the compiled data of 2003-2006 gives yet another indication of rise in cases of rubella infection in the year 2004-2005 in a small section of women who remain susceptible to primary rubella infection in child bearing age and contract the infection during pregnancy thereby leading to increase in CRS load (2005 and 2006).
A total of 2039 samples were received from the year 2003 to 2006 from Delhi government hospitals and maternity centres. The blood samples belonged to: a) babies with congenital anomalies like cataract, congenital heart problems, microcephaly, hepatosplenomegaly etc. in the age group of new born to one year, b) pregnant women suspected for in-utero infection in the past or screening for immunity against rubella,and c) women with bad obstetric history (BOH, recent abortion cases). The samples referred to NICD belonged to mixed population of urban-rural areas but mostly from low socioeconomic strata.
The serum samples were tested for the presence of rubella IgG and/or rubella IgM antibodies. Rubella IgG assays were done using indirect ELISA based kits. Rubella-IgM antibody test were performed using commercially available μ-capture enzyme immunoassay. Kit instructions were strictly adhered to while processing the samples. Positivity of IgM antibodies against rubella in a sample indicates active infection of rubella. All the CRS cases were confirmed as per the WHO case definition of laboratory confirmed (rubella IgM antibodies positive with clinical manifestations) CRS cases. ,
Women (1946, 95.4%) of child-bearing age (pregnant or cases of BOH) showed presence of rubella IgG antibodies indicating immunity against rubella [Table 1]. Few sporadic cases of in-utero rubella infection could be seen during the period of study [Table 1] but there was definite rise in the rubella infection cases in the year 2004 and 2005. Rise in in-utero cases of rubella infection was followed by a definite rise in CRS cases in newborn babies [Table 1]. Correlation found between the in-utero infection cases and CRS in babies was 0.70 during the study period.
Although there is significant decline in rubella associated congenital defects in babies by implementation of vaccination policy, a section of women (5-10%) unexposed to natural or vaccinated rubella virus remain susceptible and add the burden of CRS in society by contracting rubella infection during pregnancy as can be seen from the significant correlation between the in-utero infection cases and CRS in new-borns in the present study [Figure 1].
A safe and effective rubella vaccine is available and there are proven vaccination strategies for preventing rubella and CRS which include vaccination of children or young adults or both and assurance of immunity in women of child bearing age. WHO recommends that current efforts in global measles control should be used as an opportunity to pursue control of rubella through the use of MR and MMR vaccine. , The findings in the present study warrant that rubella is still causing considerable burden on Indian society in terms of huge number of babies born with multiple congenital anomalies. There is an urgent need to implement rubella vaccination policy in India and surveillance of susceptible women in child-bearing age and CRS load in India.
| ~ References|| |
|1.||Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital rubella syndrome: Global update. Rev Panam Salud Publica 2003;14:306-15. [PUBMED] [FULLTEXT]|
|2.||Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of Rubella and Congenital Rubella Syndrome (CRS) in developing countries, part 1: Burden of disease from CRS. Bull World Health Organ 1997;75:55-68. |
|3.||Gandhoke I, Aggarwal R, Lal S, Khare S. Seroprevalence and incidence of Rubella in and around Delhi (1988-2002). Indian J Med Microbiol 2005;23:164-7. [PUBMED] |
|4.||Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Control of Rubella and Congenital Rubella Syndrome (CRS) in developing countries, part 2: Vaccination against Rubella. Bull World Health Organ 1997;75:69-80 [PUBMED] |
|5.||Rubella vaccines. WHO position paper. Weekly Epidemiological Record, WHO, 2000;75:161-72. |
|This article has been cited by|
||Congenital rubella syndrome and rubella in Vellore, South India
| ||S. CHANDY, A. M. ABRAHAM, A. K. JANA, I. AGARWAL, A. KEKRE, G. KORULA, K. SELVARAJ, J. P. MULIYIL |
| ||Epidemiology and Infection. 2010; : 1 |
|[VIEW] | [DOI]|